Yucui Li

3.2k total citations
93 papers, 2.6k citations indexed

About

Yucui Li is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Yucui Li has authored 93 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 23 papers in Pharmacology and 22 papers in Pharmacology. Recurrent topics in Yucui Li's work include Berberine and alkaloids research (21 papers), Gout, Hyperuricemia, Uric Acid (12 papers) and Ginger and Zingiberaceae research (10 papers). Yucui Li is often cited by papers focused on Berberine and alkaloids research (21 papers), Gout, Hyperuricemia, Uric Acid (12 papers) and Ginger and Zingiberaceae research (10 papers). Yucui Li collaborates with scholars based in China, Hong Kong and Macao. Yucui Li's co-authors include Ziren Su, Jianhui Xie, Xiao‐Ping Lai, Yuhong Liu, Jiannan Chen, Yan‐Fang Xian, Cailan Li, Chaodan Luo, Huifang Zeng and Hanbin Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Yucui Li

88 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yucui Li China 30 1.2k 584 496 416 297 93 2.6k
Feng Wei China 31 1.5k 1.3× 593 1.0× 342 0.7× 514 1.2× 214 0.7× 159 3.3k
Xuegang Li China 33 1.4k 1.2× 698 1.2× 975 2.0× 407 1.0× 197 0.7× 124 3.0k
Rui‐Chao Lin China 33 2.1k 1.8× 623 1.1× 318 0.6× 563 1.4× 262 0.9× 72 3.3k
Xiaofeng Niu China 30 1.1k 1.0× 487 0.8× 412 0.8× 447 1.1× 165 0.6× 118 2.6k
Xinxin Ci China 37 2.0k 1.8× 672 1.2× 276 0.6× 335 0.8× 140 0.5× 77 4.0k
Xiaofeng Yu China 30 1.5k 1.3× 334 0.6× 360 0.7× 190 0.5× 132 0.4× 124 3.0k
Xian‐Long Cheng China 28 1.7k 1.4× 488 0.8× 349 0.7× 339 0.8× 106 0.4× 109 2.8k
Yanling Zhao China 22 848 0.7× 441 0.8× 244 0.5× 322 0.8× 66 0.2× 76 1.9k
Mian Zhang China 30 1.4k 1.2× 497 0.9× 397 0.8× 455 1.1× 135 0.5× 153 2.7k

Countries citing papers authored by Yucui Li

Since Specialization
Citations

This map shows the geographic impact of Yucui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yucui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yucui Li more than expected).

Fields of papers citing papers by Yucui Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yucui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yucui Li. The network helps show where Yucui Li may publish in the future.

Co-authorship network of co-authors of Yucui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yucui Li. A scholar is included among the top collaborators of Yucui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yucui Li. Yucui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jingzhi, Xiaowei Lu, Jincan Li, et al.. (2024). Kidney targeting and modulating macrophage polarization through AMPK signaling: Therapeutic mechanism of berberine in uric acid nephropathy. International Immunopharmacology. 138. 112632–112632. 9 indexed citations
2.
Zheng, Xiaohong, Xiaowei Lu, Baoyi Chen, et al.. (2024). Discovery of 2,8-dihydroxyadenine in HUA patients with uroliths and biomarkers for its associated nephropathy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(4). 167051–167051. 1 indexed citations
3.
Wu, Xiaoyan, Gaoxiang Ai, Hanbin Chen, et al.. (2024). 9-Hydroxy-8-oxypalmatine, a novel liver-mediated oxymetabolite of palmatine, alleviates hyperuricemia and kidney inflammation in hyperuricemic mice. Journal of Ethnopharmacology. 335. 118606–118606. 2 indexed citations
4.
Yan, Guang‐Tao, Ziwei Huang, Xinhong Wang, et al.. (2024). Sulfonation metabolism in the gut microbiota is the main metabolic pathway of cholesterol in hypercholesterolemic mice. Food & Function. 15(19). 9750–9765. 4 indexed citations
5.
Yu, Lili, et al.. (2024). Human cytomegalovirus pUL135 protein affects endothelial cell function via CD2AP in Kawasaki disease. International Journal of Cardiology. 413. 132364–132364. 1 indexed citations
6.
Huang, Ning, Mengyao Li, Liping Chen, et al.. (2024). Tetrahydroberberine alleviates high-fat diet-induced hyperlipidemia in mice via augmenting lipoprotein assembly-induced clearance of low-density lipoprotein and intermediate-density lipoprotein. European Journal of Pharmacology. 968. 176433–176433. 9 indexed citations
7.
Ai, Gaoxiang, Jian-Nan Chen, Yuhong Liu, et al.. (2022). Protective Effects of Oxyberberine in 5-Fluorouracil-Induced Intestinal Mucositis in the Mice Model. Evidence-based Complementary and Alternative Medicine. 2022. 1–15. 19 indexed citations
8.
Dou, Yaoxing, Gaoxiang Ai, Ziwei Huang, et al.. (2022). In vitro and in vivo hypoglycemia effect of oxyberberine, a novel HO-1 agonist: A renewed evidence linking HO-1 to diabetes mellitus. Phytomedicine. 101. 154135–154135. 12 indexed citations
9.
Li, Minhua, Qiuxia Yu, Ziwei Huang, et al.. (2022). Anti-Inflammatory Activation of Phellodendri Chinensis Cortex is Mediated by Berberine Erythrocytes Self-Assembly Targeted Delivery System. Drug Design Development and Therapy. Volume 16. 4365–4383. 6 indexed citations
10.
Yuan, Guangsheng, Yucui Li, Hui He, et al.. (2021). Identification and fine mapping of a recessive gene controlling zebra leaf phenotype in maize. Molecular Breeding. 41(2). 9–9. 2 indexed citations
11.
Xu, Lieqiang, Qiuxia Yu, Qiaoping Li, et al.. (2021). Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate- and Hypoxanthine-Induced Hyperuricemic Mice. Frontiers in Pharmacology. 12. 645879–645879. 60 indexed citations
12.
13.
Wang, Lan, Xie Zhang, Yongxian Li, et al.. (2016). Aqueous Extract of Clerodendranthus spicatus Exerts Protective Effect on UV‐Induced Photoaged Mice Skin. Evidence-based Complementary and Alternative Medicine. 2016(1). 9623957–9623957. 6 indexed citations
14.
Li, Chuwen, Zhiwei Chen, Xiaoli Wu, et al.. (2015). A Standardized Traditional Chinese Medicine Preparation Named Yejuhua Capsule Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice via Downregulating Toll-Like Receptor 4/Nuclear Factor-κB. Evidence-based Complementary and Alternative Medicine. 2015. 1–15. 7 indexed citations
15.
16.
Chen, Haiming, Zuqing Su, Shaozhen Hou, et al.. (2014). White Pepper and Piperine Have Different Effects on Pharmacokinetics of Puerarin in Rats. Evidence-based Complementary and Alternative Medicine. 2014(1). 796890–796890. 13 indexed citations
17.
Li, Chuwen, Xiaoli Wu, Zuqing Su, et al.. (2013). Anti‐Inflammatory Property of the Ethanol Extract of the Root and Rhizome of Pogostemon cablin (Blanco) Benth. The Scientific World JOURNAL. 2013(1). 434151–434151. 29 indexed citations
18.
Li, Yucui, Haiming Chen, Lirong Tan, et al.. (2012). Anti-Candida albicans activity and pharmacokinetics of pogostone isolated from Pogostemonis Herba. Phytomedicine. 20(1). 77–83. 51 indexed citations
19.
Xian, Yan‐Fang, Yucui Li, Siu‐Po Ip, et al.. (2011). Anti-inflammatory effect of patchouli alcohol isolated from Pogostemonis Herba in LPS-stimulated RAW264.7 macrophages. Experimental and Therapeutic Medicine. 2(3). 545–550. 90 indexed citations
20.
Li, Yucui, Yan‐Fang Xian, Siu‐Po Ip, et al.. (2011). Anti-inflammatory activity of patchouli alcohol isolated from Pogostemonis Herba in animal models. Fitoterapia. 82(8). 1295–1301. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feng Wei Breakdown of academic impact, for papers by Xuegang Li Breakdown of academic impact, for papers by Rui‐Chao Lin Breakdown of academic impact, for papers by Xiaofeng Niu Breakdown of academic impact, for papers by Xinxin Ci Breakdown of academic impact, for papers by Xiaofeng Yu Breakdown of academic impact, for papers by Xian‐Long Cheng Breakdown of academic impact, for papers by Yanling Zhao Breakdown of academic impact, for papers by Mian Zhang
Rankless by CCL
2026